Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 701 of 767

Advanced search

🌍Oct 31Industrygedeonrichter.comTier 1 · Company source

Voting rights, registered capital

Gedeon RichterOriginal source

🌍Oct 31Industrygedeonrichter.comTier 1 · Company source

Voting rights, registered capital

Gedeon RichterOriginal source

🌍Oct 31Industrygedeonrichter.comTier 1 · Company source

Transaction with Treasury shares

Gedeon RichterOriginal source

🇨🇭Oct 31CDMObachem.comTier 2 · Direct publisher

Anne-Kathrin Stoller to become new CEO at Bachem

Bachem PeptidesOriginal source

🌍Oct 30Industryevidana.comTier 1 · Company source

Why Every Home Cook Needs a Micro Pressure Cooker in Their Kitchen

EvidanaOriginal source

🌍Oct 30Industrysignanthealth.comTier 1 · Company source

Signant Health Appoints John Harrison as Clinical Vice President

Signant HealthOriginal source

🇩🇪Oct 30CDMOformycon.comTier 2 · Direct publisher

Far Beyond The Skin – Psoriasis und Begleiterkrankungen

FormyconOriginal source

🇺🇸Oct 30Industrygenesis.mlTier 3 · Secondary coverage

Genesis says its new AI model bests AlphaFold 3

Genesis TherapeuticsOriginal source

🇦🇹Oct 30Devicescontextflow.comTier 1 · Company source

contextflow collaborates with VUNO and Mesalvo to advance cardiac arrest prediction solution

contextflow (ADVANCE Chest CT Lung)Original source

🇺🇸Oct 29Researchpodcasters.spotify.comTier 3 · Secondary coverage

On the frontiers of research at the Lux AI Summit

Lux CapitalOriginal source

🇯🇵Oct 29Devicesolympus-global.comTier 1 · Company source

Olympus Introduces a NBI+TXI™ Observation Mode to the EVIS X1™ Endoscopy System CV-1500 Video System Center

Olympus MedicalOriginal source

🌍Oct 29Industrypowerfulmedical.comTier 1 · Company source

PMcardio Reports Positive RCT Results and Late-Breaking Clinical Science for STEMI Detection

Powerful MedicalOriginal source

🇺🇸Oct 29Industrygenesis.mlTier 3 · Secondary coverage

Genesis Molecular AI Unveils Pearl

Genesis TherapeuticsOriginal source

🇺🇸Oct 29Industrygenesis.mlTier 3 · Secondary coverage

Introducing Pearl: The Next Generation Foundation Model for Drug Discovery

Genesis TherapeuticsOriginal source

🌍Oct 28Researchcatalystcr.comTier 2 · Direct publisher

Reflections from ESMO 2025

Catalyst Clinical ResearchOriginal source

🇫🇷Oct 28Researchpresse.inserm.frTier 2 · Direct publisher

Researchers develop an ultrasound probe capable of imaging an entire organ in 4D

INSERMOriginal source

🇨🇭Oct 28Industryatinary.comTier 1 · Company source

Atinary is now listed on AWS Marketplace

Atinary TechnologiesOriginal source

🇩🇪Oct 27Mediadzne.deTier 2 · Direct publisher

Dementia: New Model of Home Care Proves Effective in Practice

DZNE (Neurodegenerative Diseases)Original source

🇳🇴Oct 27Researchuib.noTier 2 · Direct publisher

Scientists discovered a unique ecosystem under the Arctic

University of BergenOriginal source

🇨🇭Oct 24, 2025Industryatinary.comTier 1 · Company source

Atinary’s SDLabs Platform is SOC 2 Compliant

Atinary TechnologiesOriginal source

🌍Oct 23, 2025Industrymyriad.comTier 3 · Secondary coverage

Enhancing Prostate Cancer Genomics with AI-Powered Morphometric Analysis

MyriadOriginal source

🌍Oct 23, 2025Industryoramed.comTier 1 · Company source

Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives

Oramed PharmaceuticalsOriginal source

🇨🇭Oct 23, 2025CDMObachem.comTier 2 · Direct publisher

Bachem secures financing of strategic growth initiatives

Bachem PeptidesOriginal source

🇨🇭Oct 23, 2025CDMObachem.comTier 2 · Direct publisher

Bachem announces progress in Building K start-up and expansion of its site in Vista, CA

Bachem PeptidesOriginal source

🇺🇸Oct 23, 2025CROinvestor.medpace.comTier 2 · Direct publisher

Medpace Holdings, Inc. Reports Third Quarter 2025 Results

MedpaceOriginal source

🇺🇸Oct 22, 2025Researchpodcasters.spotify.comTier 3 · Secondary coverage

The present and future of wargaming

Lux CapitalOriginal source

🇺🇸Oct 22, 2025Industrygenesis.mlTier 3 · Secondary coverage

Triangle Multiplication Is All You Need For Biomolecular Structure Representations

Genesis TherapeuticsOriginal source

🇺🇰Oct 21, 2025Researchstemcells.cam.ac.ukTier 2 · Direct publisher

CSCI’s Professor Sarah Teichmann elected to the US National Academy of Medicine

Cambridge Stem Cell InstituteOriginal source

🇯🇵Oct 21, 2025Devicesolympus-global.comTier 1 · Company source

Olympus Launches New Surgical Energy Device for Hemostatic Cutting and Vessel Sealing

Olympus MedicalOriginal source

🇫🇷Oct 21, 2025Industryastraveus.comTier 1 · Company source

Astraveus further strengthens world class leadership team to advance development of Lakhesys Benchtop Cell Factory™

AstraveusOriginal source

🇯🇵Oct 21, 2025Devicesolympus-global.comTier 1 · Company source

Olympus: Feasibility Study on Endoscopy Infection Control Systems in India Selected for METI’s “Global South Co-Creation Subsidy Program”

Olympus MedicalOriginal source

🌍Oct 21, 2025Regulatorysocra.orgTier 1 · Regulatory source

Celebrate the 2025 President’s Award for Outstanding Service to SOCRA Winner, Abby Statler, PhD, MPH, MA, CCRP

SOCRA SocietyOriginal source

🇺🇸Oct 20, 2025Industrybrukercellularanalysis.comTier 3 · Secondary coverage

Perfusion: The Beating Heart of Single-Cell Biology and Cancer Immunotherapy

Berkeley LightsOriginal source

🌍Oct 20, 2025Industrybicara.comTier 1 · Company source

ESMO 2025 Poster Presentation: Ficerafusp alfa-driven tumor penetration via EMT and FMT inhibition in the tumor microenviornment

Bicara TherapeuticsOriginal source

🇺🇰Oct 20, 2025Industryadaptimmune.comTier 1 · Company source

Adaptimmune Announces Delisting from Nasdaq

AdaptimmuneOriginal source

🌍Oct 20, 2025Industryabelzeta.comTier 1 · Company source

AbelZeta Announces Late-Breaking Poster Presentation at ACR Convergence 2025 of First-in-Human Phase I Trial of anti-CD20/BCMA Bispecific CAR-T Therapy in Patients with Refractory Autoimmune Diseases

AbelZeta PharmaOriginal source

🇳🇴Oct 20, 2025Researchuib.noTier 2 · Direct publisher

Celebrating 30 Years of the Nordic Library at Athens

University of BergenOriginal source

🌍Oct 17, 2025Regulatoryravimiamet.eeTier 1 · Regulatory source

Statistical Yearbook 2025 of the State Agency of Medicines

SAM EstoniaOriginal source

🇺🇸Oct 17, 2025Industrybeamtx.comTier 1 · Company source

Expanded Access | Beam Therapeutics

Beam TherapeuticsOriginal source

🌍Oct 16, 2025Industrymeridianbioscience.comTier 1 · Company source

Meridian Bioscience Appoints New CEO and Executive Team to Accelerate Global Growth

Meridian BioscienceOriginal source

🇯🇵Oct 16, 2025Deviceshoya.comTier 1 · Company source

C2 CryoBalloon Technology: Asset Purchase Agreement with Merit Medical Systems

HOYA CorporationOriginal source

🌍Oct 15, 2025Regulatoryima.isTier 1 · Regulatory source

RMS requests and national applications

IMA IcelandOriginal source

🇳🇴Oct 15, 2025Researchuib.noTier 2 · Direct publisher

Wits/SapienCE wins top cultural award

University of BergenOriginal source

🇨🇭Oct 15, 2025Industryalentis.chTier 1 · Company source

Alentis Appoints Mark Pruzanski as CEO

Alentis TherapeuticsOriginal source

🇮🇹Oct 14, 2025CDMOflammagroup.comTier 2 · Direct publisher

Flamma Selected For 2025 CDMO Leadership Awards Europe

Flamma GroupOriginal source

🇺🇸Oct 14, 2025Researchmdanderson.orgTier 2 · Direct publisher

What's new with kidney cancer and renal cell carcinoma treatment?

MD Anderson Cancer CenterOriginal source

🇯🇵Oct 14, 2025Devicesolympus-global.comTier 1 · Company source

A new “True to Life Story” featuring the fight with cancer of former WBA champion Shinji Takehara

Olympus MedicalOriginal source

🌍Oct 12, 2025Industrymeridianbioscience.comTier 1 · Company source

Smarter Library Prep for Whole Genome Sequencing

Meridian BioscienceOriginal source

🌍Oct 10, 2025Industrypsomagen.comTier 1 · Company source

Two Years Later: Psomagen’s Participation in the TOPMed 2.0 Program

PsomagenOriginal source

🇺🇸Oct 10, 2025Researcharchventure.comTier 2 · Direct publisher

Bristol Myers Squibb acquires Orbital Therapeutics and its In Vivo RNA platform

ARCH Venture PartnersOriginal source

🌍Oct 9, 2025Industryevidana.comTier 1 · Company source

Discover the Game-Changer: Elevate Your Play with the Best Wireless Gaming Headset

EvidanaOriginal source

🇺🇸Oct 9, 2025CROcelerion.comTier 2 · Direct publisher

Celerion Earns AAHRPP Full Reaccreditation for Five Years, Strengthening Commitment to Ethical Research Practices

CelerionOriginal source

🇩🇪Oct 9, 2025CDMOformycon.comTier 2 · Direct publisher

Sehkraft erhalten – Anti-VEGF-Therapien gegen schwere Retinopathien

FormyconOriginal source

🌍Oct 8, 2025Mediascience37.comTier 2 · Direct publisher

Science 37 Completes Third FDA Inspection, Validating Quality of its Direct-to-Patient Site in Pivotal Phase 3 Rare Disease Trial

Science 37Original source

🇫🇷Oct 8, 2025CDMOaxplora.comTier 3 · Secondary coverage

Axplora initiates global investments exceeding €100m in 2025

NovasepOriginal source

🌍Oct 8, 2025Industrymyriad.comTier 3 · Secondary coverage

Myriad Genetics’ continued investment in molecular residual disease (MRD) testing drives new patents granted

MyriadOriginal source

🇺🇸Oct 7, 2025Devicesaccuray.comTier 1 · Company source

Exploring the Impact of Advanced Radiosurgery on Trigeminal Neuralgia

AccurayOriginal source

🌍Oct 7, 2025Industrycuris.comTier 1 · Company source

Emavusertib in Combination with Gemcitabine and Nab-paclitaxel in Metastatic or Unresectable Pancreatic Ductal Adenocarcinoma AACR 2025 Poster

CurisOriginal source

🌍Oct 7, 2025Industryskyebioscience.comTier 1 · Company source

CBeyond P2a Data: Nimacimab as Mono and Combination Therapy

Skye BioscienceOriginal source

🇺🇸Oct 6, 2025Industryclinicalink.comTier 1 · Company source

Clinical ink announces selection as finalist for 2025 Prix Galien USA, “Best Digital Health Solution”

Clinical InkOriginal source